Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy
Authors:
- Gonzalo Rodríguez-BerrigueteGRGonzalo Rodríguez-Berriguete
- Norelia TorrealbaNTNorelia Torrealba
- Miguel Angel OrtegaMiguel Angel Ortega
- Pilar Martínez-OnsurbePMPilar Martínez-Onsurbe
- Gabriel OlmedillaGOGabriel Olmedilla
- Ricardo PaniaguaRPRicardo Paniagua
- Manuel Guil-CidMGManuel Guil-Cid
- Benito FraileBFBenito Fraile
- Mar RoyuelaMRMar Royuela
Open Access
- 27 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 809
Abstract
The expression status of apoptotic regulators, such as caspases and inhibitors of apoptosis proteins (IAPs), could reflect the aggressiveness of tumors and, therefore, could be useful as prognostic markers. We explored the associations between tumor expression of caspases and IAPs and clinicopathological features of prostate cancer – clinical and pathological T stage, Gleason score, preoperative serum PSA levels, perineural invasion, lymph node involvement, surgical margin status and overall survival – and evaluated its capability to predict biochemical progression after radical prostatectomy. Protein expression of caspases (procaspase-8, cleaved caspase-8, procaspase-3, cleaved caspase-3, caspase-7 and procaspase-9) and IAPs (cIAP1/2, cIAP2, NAIP, Survivin and XIAP) was analyzed by immunohistochemistry in radical prostatectomy samples from 84 prostate cancer patients. Spearman’s test, Kaplan-Meier curves, and univariate and multivariate Cox proportional hazard regression analysis were performed. cIAP1/2, cIAP2, Survivin, procaspase-8, cleaved caspase-8, procaspase-3 and caspase-7 expression correlated with at least one clinicopathological feature of the disease. Patients negative for XIAP, procaspase-3 or cleaved caspase-3 had a significantly worse prognosis. Of note, XIAP, procaspase-3 and cleaved caspase-3 were predictors of biochemical progression independent of Gleason score and pathological T stage. Our results indicate that alterations in the expression of IAPs and caspases contribute to the malignant behavior of prostate tumors and suggest that tumor expression of XIAP, procaspase-3 and cleaved caspase-3 may help to identify prostate cancer patients at risk of progression.Keywords
This publication has 35 references indexed in Scilit:
- Genetic Variants in CASP3, BMP5, and IRS2 Genes May Influence Survival in Prostate Cancer Patients Receiving Androgen-Deprivation TherapyPLOS ONE, 2012
- Association of Caspases with an Increased Prostate Cancer Risk in North Indian PopulationDNA and Cell Biology, 2012
- Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase ActivationJournal of Biological Chemistry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Apoptosis, Stem Cells, and Tissue RegenerationScience Signaling, 2010
- Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostateBMC Cancer, 2010
- Novel Combinations for the Treatment of Metastatic Breast CancerCancers, 2010
- Role for X-linked Inhibitor of Apoptosis Protein Upstream of Mitochondrial PermeabilizationJournal of Biological Chemistry, 2010
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences, 2008
- X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer modelCell Death & Differentiation, 2008